• Species Reactivity

  Human

• Specificity

  Detects human FGF-13 1B in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) FGF-3, -4, -5, -6, -7, -9, -10, -11, -12, -16, -17, -19, -20, -21, rhFGF basic, recombinant mouse FGF-8b, or -8c is observed.

• Source

  Monoclonal Mouse IgG2a Clone # 298923

• Immunogen

  E. coli-derived recombinant human FGF-13 isoform 1B    
  Ala2-Thr192    
  Accession # NP_378668

• Formulation

  Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.

• Label

  Alexa Fluor 594

Applications

• 
  

  Recommended    
  Concentration

  Sample

• Flow Cytometry

  0.25-1 µg/10    ⁶ cells

  RPMI 8226 human multiple myeloma cell line fixed with Flow Cytometry Fixation Buffer (Catalog # ) and permeabilized with Flow Cytometry Permeabilization/Wash Buffer I (Catalog # )

• 
  

Please Note: Optimal dilutions should be determined by each laboratory for each application.  are available in the Technical Information section on our website.

Preparation and Storage

• Stability & Storage

  Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Background: FGF-13

FGF-13 (Fibroblast Growth Factor-13), also known as FGF homologous factor 2 (FHF-2), is a member of the FGF family. It is expressed in brain and skeletal muscle and has been implicated in nervous system development and function. The gene for FGF-13 has been localized in human chromosome X, in a region associated with Borjeson-Forssman-Lehmann syndrome, a syndromal X-linked mental retardation. Two alternately spliced isoforms that differ in their amino-terminal residues have been described.

• Long Name:

  Fibroblast Growth Factor 13

• Entrez Gene IDs:

  2258 (Human)

• Alternate Names:

  FGF13; FGF-13; FGF2Fibroblast growth factor homologous factor 2; FHF2FHF-2; fibroblast growth factor 13